Laurus Labs Limited (the Company) has signed definitive agreements today (i.e. November 25 2020) with the Sellers i.e. Eight Roads Ventures and VenturEast Proactive Fund and VenturEast Life Fund III to acquire 72.55% stake in Richcore Lifesciences Private Limited (Richcore) a Biotechnology Company subject to completion of conditions precedent by way of cash consideration of Rs. 246.67 Crores.